NK Cells Market Report

Global NK Cells Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • POSTDATE：Apr 06, 2021
  • PAGES：211
  • REPORT CODE：GMM642258
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The NK Cells is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of XX.0% during the forecast period. The research provides insights for the global NK Cells market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the NK Cells industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Global NK Cells Market Segmentations:

    By Players:

    • Innate Pharma SA (France)

    • Bristol-Myers Squibb (USA)

    • Chipscreen Biosciences (China)

    • NantKwest Inc (USA)

    • Affimed NV (Netherlands)

    • NKT Therapeutics (USA)

    • Altor BioScience Corporation (USA)

    • Takeda Pharmaceutical (Japan)

    • Sorrento Therapeutics Inc (USA)

    By Types:

    • Mogamulizumab

    • Lorvotuzumab Mertansine

    • Others

    By End-User:

    • Cancer

    • Cardiovascular Diseases

    • Others

    By Regions:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of NK Cells Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global NK Cells Market Size and Growth Rate of Mogamulizumab from 2014 to 2026

      • 1.3.2 Global NK Cells Market Size and Growth Rate of Lorvotuzumab Mertansine from 2014 to 2026

      • 1.3.3 Global NK Cells Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global NK Cells Market Size and Growth Rate of Cancer from 2014 to 2026

      • 1.4.2 Global NK Cells Market Size and Growth Rate of Cardiovascular Diseases from 2014 to 2026

      • 1.4.3 Global NK Cells Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America NK Cells Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.1 United States NK Cells Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.2 Canada NK Cells Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.3 Mexico NK Cells Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe NK Cells Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.1 Germany NK Cells Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.2 UK NK Cells Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.3 France NK Cells Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.4 Italy NK Cells Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.5 Nordic Countries NK Cells Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.6 Spain NK Cells Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.7 Belgium NK Cells Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.8 Poland NK Cells Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.9 Russia NK Cells Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.10 Turkey NK Cells Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific NK Cells Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.1 China NK Cells Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.2 Japan NK Cells Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.3 Australia and New Zealand NK Cells Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.4 India NK Cells Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.5 ASEAN Countries NK Cells Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.6 South Korea NK Cells Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Latin America, Middle East & Africa NK Cells Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.1 GCC Countries NK Cells Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.2 Brazil NK Cells Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.3 Nigeria NK Cells Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.4 South Africa NK Cells Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.5 Argentina NK Cells Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of NK Cells Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of NK Cells by Major Types

      • 3.4.1 NK Cells Market Size and Growth Rate of Mogamulizumab

      • 3.4.2 NK Cells Market Size and Growth Rate of Lorvotuzumab Mertansine

      • 3.4.3 NK Cells Market Size and Growth Rate of Others

    4 Segmentation of NK Cells Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of NK Cells by Major End-Users

      • 4.4.1 Market Size and Growth Rate of NK Cells in Cancer

      • 4.4.2 Market Size and Growth Rate of NK Cells in Cardiovascular Diseases

      • 4.4.3 Market Size and Growth Rate of NK Cells in Others

    5 Market Analysis by Major Regions

    • 5.1 Global NK Cells Production Analysis by Major Regions

    • 5.2 Global NK Cells Consumption Analysis by Major Regions

    • 5.3 Global NK Cells Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America NK Cells Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe NK Cells Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific NK Cells Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa NK Cells Production, Import, Consumption and Export Analysis

    6 Product Commodity of NK Cells Market in Major Countries

    • 6.1 Top 5 Export Countries in NK Cells market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in NK Cells market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in NK Cells market from 2014 to 2019

    • 6.2 Top 5 Import Countries in NK Cells market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in NK Cells market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in NK Cells market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7 North America NK Cells Landscape Analysis

    • 7.1 North America NK Cells Landscape Analysis by Major Types

    • 7.2 North America NK Cells Landscape Analysis by Major End-Users

    • 7.3 North America NK Cells Landscape Analysis by Major Countries

      • 7.3.1 United States NK Cells Market Volume and Growth Rate

      • 7.3.2 Canada NK Cells Market Volume and Growth Rate

      • 7.3.3 Mexico NK Cells Market Volume and Growth Rate

    8 Europe NK Cells Landscape Analysis

    • 8.1 Europe NK Cells Landscape Analysis by Major Types

    • 8.2 Europe NK Cells Landscape Analysis by Major End-Users

    • 8.3 Europe NK Cells Landscape Analysis by Major Countries

      • 8.3.1 Germany NK Cells Market Volume and Growth Rate

      • 8.3.2 UK NK Cells Market Volume and Growth Rate

      • 8.3.3 France NK Cells Market Volume and Growth Rate

      • 8.3.4 Italy NK Cells Market Volume and Growth Rate

      • 8.3.5 Nordic Countries NK Cells Market Volume and Growth Rate

      • 8.3.6 Spain NK Cells Market Volume and Growth Rate

      • 8.3.7 Belgium NK Cells Market Volume and Growth Rate

      • 8.3.8 Poland NK Cells Market Volume and Growth Rate

      • 8.3.9 Russia NK Cells Market Volume and Growth Rate

      • 8.3.10 Turkey NK Cells Market Volume and Growth Rate

    9 Asia Pacific NK Cells Landscape Analysis

    • 9.1 Asia Pacific NK Cells Landscape Analysis by Major Types

    • 9.2 Asia Pacific NK Cells Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific NK Cells Landscape Analysis by Major Countries

      • 9.3.1 China NK Cells Market Volume and Growth Rate

      • 9.3.2 Japan NK Cells Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand NK Cells Market Volume and Growth Rate

      • 9.3.4 India NK Cells Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries NK Cells Market Volume and Growth Rate

      • 9.3.6 South Korea NK Cells Market Volume and Growth Rate

    10 Latin America, Middle East & Africa NK Cells Landscape Analysis

    • 10.1 Latin America, Middle East & Africa NK Cells Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa NK Cells Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa NK Cells Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries NK Cells Market Volume and Growth Rate

      • 10.3.2 Brazil NK Cells Market Volume and Growth Rate

      • 10.3.3 Nigeria NK Cells Market Volume and Growth Rate

      • 10.3.4 South Africa NK Cells Market Volume and Growth Rate 

      • 10.3.5 Argentina NK Cells Market Volume and Growth Rate

    11 Major Players Profile

    • 11.1 Innate Pharma SA (France)

      • 11.1.1 Innate Pharma SA (France) Company Profile and Recent Development

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Bristol-Myers Squibb (USA)

      • 11.2.1 Bristol-Myers Squibb (USA) Company Profile and Recent Development

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Chipscreen Biosciences (China)

      • 11.3.1 Chipscreen Biosciences (China) Company Profile and Recent Development

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 NantKwest Inc (USA)

      • 11.4.1 NantKwest Inc (USA) Company Profile and Recent Development

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Affimed NV (Netherlands)

      • 11.5.1 Affimed NV (Netherlands) Company Profile and Recent Development

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 NKT Therapeutics (USA)

      • 11.6.1 NKT Therapeutics (USA) Company Profile and Recent Development

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 Altor BioScience Corporation (USA)

      • 11.7.1 Altor BioScience Corporation (USA) Company Profile and Recent Development

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 Takeda Pharmaceutical (Japan)

      • 11.8.1 Takeda Pharmaceutical (Japan) Company Profile and Recent Development

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 Sorrento Therapeutics Inc (USA)

      • 11.9.1 Sorrento Therapeutics Inc (USA) Company Profile and Recent Development

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

    12 Data Source and Research Methodology

    The List of Tables and Figures (Totals 122 Figures and 145 Tables)

    • Figure Product Picture

    • Figure NK Cells Market Size and Growth Rate of Mogamulizumab from 2014 to 2026

    • Figure NK Cells Market Size and Growth Rate of Lorvotuzumab Mertansine from 2014 to 2026

    • Figure NK Cells Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Global NK Cells Market Size and Growth Rate of Cancer from 2014 to 2026

    • Figure Global NK Cells Market Size and Growth Rate of Cardiovascular Diseases from 2014 to 2026

    • Figure Global NK Cells Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure North America NK Cells Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure United States NK Cells Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Canada NK Cells Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico NK Cells Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Europe NK Cells Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Germany NK Cells Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure UK NK Cells Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure France NK Cells Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Italy NK Cells Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries NK Cells Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Spain NK Cells Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium NK Cells Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Poland NK Cells Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Russia NK Cells Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey NK Cells Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific NK Cells Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure China NK Cells Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Japan NK Cells Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Australia and New Zealand NK Cells Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure India NK Cells Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries NK Cells Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea NK Cells Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Latin America, Middle East & Africa NK Cells Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Countries NK Cells Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil NK Cells Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nigeria NK Cells Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa NK Cells Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina NK Cells Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of NK Cells Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of NK Cells

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of NK Cells by Different Types from 2014 to 2026

    • Table Consumption Share of NK Cells by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Mogamulizumab

    • Figure Market Size and Growth Rate of Lorvotuzumab Mertansine

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of NK Cells by Different End-Users from 2014 to 2026

    • Table Consumption Share of NK Cells by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Cancer

    • Figure Market Size and Growth Rate of Cardiovascular Diseases

    • Figure Market Size and Growth Rate of Others

    • Table Global NK Cells Production by Major Regions

    • Table Global NK Cells Production Share by Major Regions

    • Figure Global NK Cells Production Share by Major Regions in 2014

    • Figure Global NK Cells Production Share by Major Regions in 2018

    • Figure Global NK Cells Production Share by Major Regions in 2026

    • Table Global NK Cells Consumption by Major Regions

    • Table Global NK Cells Consumption Share by Major Regions

    • Figure Global NK Cells Consumption Share by Major Regions in 2014

    • Figure Global NK Cells Consumption Share by Major Regions in 2018

    • Figure Global NK Cells Consumption Share by Major Regions in 2026

    • Table North America NK Cells Production, Import, Consumption and Export Analysis

    • Table Europe NK Cells Production, Import, Consumption and Export Analysis

    • Table Asia Pacific NK Cells Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa NK Cells Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in NK Cells market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in NK Cells market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in NK Cells market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in NK Cells market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America NK Cells Consumption by Types from 2014 to 2026

    • Table North America NK Cells Consumption Share by Types from 2014 to 2026

    • Figure North America NK Cells Consumption Share by Types in 2014

    • Figure North America NK Cells Consumption Share by Types in 2018

    • Figure North America NK Cells Consumption Share by Types in 2026

    • Table North America NK Cells Consumption by End-Users from 2014 to 2026

    • Table North America NK Cells Consumption Share by End-Users from 2014 to 2026

    • Figure North America NK Cells Consumption Share by End-Users in 2014

    • Figure North America NK Cells Consumption Share by End-Users in 2018

    • Figure North America NK Cells Consumption Share by End-Users in 2026

    • Table North America NK Cells Consumption by Major Countries from 2014 to 2026

    • Table North America NK Cells Consumption Share by Major Countries from 2014 to 2026

    • Figure North America NK Cells Consumption Share by Major Countries in 2014

    • Figure North America NK Cells Consumption Share by Major Countries in 2018

    • Figure North America NK Cells Consumption Share by Major Countries in 2026

    • Figure United States NK Cells Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada NK Cells Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico NK Cells Market Volume and Growth Rate from 2014 to 2026

    • Table Europe NK Cells Consumption by Types from 2014 to 2026

    • Table Europe NK Cells Consumption Share by Types from 2014 to 2026

    • Figure Europe NK Cells Consumption Share by Types in 2014

    • Figure Europe NK Cells Consumption Share by Types in 2018

    • Figure Europe NK Cells Consumption Share by Types in 2026

    • Table Europe NK Cells Consumption by End-Users from 2014 to 2026

    • Table Europe NK Cells Consumption Share by End-Users from 2014 to 2026

    • Figure Europe NK Cells Consumption Share by End-Users in 2014

    • Figure Europe NK Cells Consumption Share by End-Users in 2018

    • Figure Europe NK Cells Consumption Share by End-Users in 2026

    • Table Europe NK Cells Consumption by Major Countries from 2014 to 2026

    • Table Europe NK Cells Consumption Share by Major Countries from 2014 to 2026

    • Figure Europe NK Cells Consumption Share by Major Countries in 2014

    • Figure Europe NK Cells Consumption Share by Major Countries in 2018

    • Figure Europe NK Cells Consumption Share by Major Countries in 2026

    • Figure Germany NK Cells Market Volume and Growth Rate from 2014 to 2026

    • Figure UK NK Cells Market Volume and Growth Rate from 2014 to 2026

    • Figure France NK Cells Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy NK Cells Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Countries NK Cells Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium NK Cells Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland NK Cells Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia NK Cells Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey NK Cells Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific NK Cells Consumption by Types from 2014 to 2026

    • Table Asia Pacific NK Cells Consumption Share by Types from 2014 to 2026

    • Figure Asia Pacific NK Cells Consumption Share by Types in 2014

    • Figure Asia Pacific NK Cells Consumption Share by Types in 2018

    • Figure Asia Pacific NK Cells Consumption Share by Types in 2026

    • Table Asia Pacific NK Cells Consumption by End-Users from 2014 to 2026

    • Table Asia Pacific NK Cells Consumption Share by End-Users from 2014 to 2026

    • Figure Asia Pacific NK Cells Consumption Share by End-Users in 2014

    • Figure Asia Pacific NK Cells Consumption Share by End-Users in 2018

    • Figure Asia Pacific NK Cells Consumption Share by End-Users in 2026

    • Table Asia Pacific NK Cells Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific NK Cells Consumption Share by Major Countries from 2014 to 2026

    • Figure Asia Pacific NK Cells Consumption Share by Major Countries in 2014

    • Figure Asia Pacific NK Cells Consumption Share by Major Countries in 2018

    • Figure Asia Pacific NK Cells Consumption Share by Major Countries in 2026

    • Figure China NK Cells Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan NK Cells Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia and New ZealandNK Cells Market Volume and Growth Rate from 2014 to 2026

    • Figure India NK Cells Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries NK Cells Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea NK Cells Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa NK Cells Consumption by Types from 2014 to 2026

    • Table Latin America, Middle East & Africa NK Cells Consumption Share by Types from 2014 to 2026

    • Figure Latin America, Middle East & Africa NK Cells Consumption Share by Types in 2014

    • Figure Latin America, Middle East & Africa NK Cells Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa NK Cells Consumption Share by Types in 2026

    • Table Latin America, Middle East & Africa NK Cells Consumption by End-Users from 2014 to 2026

    • Table Latin America, Middle East & Africa NK Cells Consumption Share by End-Users from 2014 to 2026

    • Figure Latin America, Middle East & Africa NK Cells Consumption Share by End-Users in 2014

    • Figure Latin America, Middle East & Africa NK Cells Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa NK Cells Consumption Share by End-Users in 2026

    • Table Latin America, Middle East & Africa NK Cells Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa NK Cells Consumption Share by Major Countries from 2014 to 2026

    • Figure Latin America, Middle East & Africa NK Cells Consumption Share by Major Countries in 2014

    • Figure Latin America, Middle East & Africa NK Cells Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa NK Cells Consumption Share by Major Countries in 2026

    • Figure GCC Countries NK Cells Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil NK Cells Market Volume and Growth Rate from 2014 to 2026

    • Figure Nigeria NK Cells Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa NK Cells Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina NK Cells Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Innate Pharma SA (France)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Innate Pharma SA (France)

    • Figure Sales and Growth Rate Analysis of Innate Pharma SA (France)

    • Figure Revenue and Market Share Analysis of Innate Pharma SA (France)

    • Table Product and Service Introduction of Innate Pharma SA (France)

    • Table Company Profile and Development Status of Bristol-Myers Squibb (USA)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb (USA)

    • Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb (USA)

    • Figure Revenue and Market Share Analysis of Bristol-Myers Squibb (USA)

    • Table Product and Service Introduction of Bristol-Myers Squibb (USA)

    • Table Company Profile and Development Status of Chipscreen Biosciences (China)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Chipscreen Biosciences (China)

    • Figure Sales and Growth Rate Analysis of Chipscreen Biosciences (China)

    • Figure Revenue and Market Share Analysis of Chipscreen Biosciences (China)

    • Table Product and Service Introduction of Chipscreen Biosciences (China)

    • Table Company Profile and Development Status of NantKwest Inc (USA)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of NantKwest Inc (USA)

    • Figure Sales and Growth Rate Analysis of NantKwest Inc (USA)

    • Figure Revenue and Market Share Analysis of NantKwest Inc (USA)

    • Table Product and Service Introduction of NantKwest Inc (USA)

    • Table Company Profile and Development Status of Affimed NV (Netherlands)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Affimed NV (Netherlands)

    • Figure Sales and Growth Rate Analysis of Affimed NV (Netherlands)

    • Figure Revenue and Market Share Analysis of Affimed NV (Netherlands)

    • Table Product and Service Introduction of Affimed NV (Netherlands)

    • Table Company Profile and Development Status of NKT Therapeutics (USA)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of NKT Therapeutics (USA)

    • Figure Sales and Growth Rate Analysis of NKT Therapeutics (USA)

    • Figure Revenue and Market Share Analysis of NKT Therapeutics (USA)

    • Table Product and Service Introduction of NKT Therapeutics (USA)

    • Table Company Profile and Development Status of Altor BioScience Corporation (USA)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Altor BioScience Corporation (USA)

    • Figure Sales and Growth Rate Analysis of Altor BioScience Corporation (USA)

    • Figure Revenue and Market Share Analysis of Altor BioScience Corporation (USA)

    • Table Product and Service Introduction of Altor BioScience Corporation (USA)

    • Table Company Profile and Development Status of Takeda Pharmaceutical (Japan)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda Pharmaceutical (Japan)

    • Figure Sales and Growth Rate Analysis of Takeda Pharmaceutical (Japan)

    • Figure Revenue and Market Share Analysis of Takeda Pharmaceutical (Japan)

    • Table Product and Service Introduction of Takeda Pharmaceutical (Japan)

    • Table Company Profile and Development Status of Sorrento Therapeutics Inc (USA)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sorrento Therapeutics Inc (USA)

    • Figure Sales and Growth Rate Analysis of Sorrento Therapeutics Inc (USA)

    • Figure Revenue and Market Share Analysis of Sorrento Therapeutics Inc (USA)

    • Table Product and Service Introduction of Sorrento Therapeutics Inc (USA)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US